Market Overview:
The global alogliptin benzoate API market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of diabetes, rising demand for novel antidiabetic drugs, and growing investments by pharmaceutical companies in R&D activities. Based on type, the global alogliptin benzoate API market can be segmented into min purity less than 98%, min purity 98%-99%, and min purity more than 99%. The min purity less than 98% segment is expected to account for the largest share of the global alogliptin benzoate API market in 2018. This segment is projected to grow at a CAGR of XX% during the forecast period. The growth in this segment can be attributed to its low cost and easy availability. Based on application, the global alogliptin benzoate API market can be divided into research and pharmaceuticals segments. The research segment is projected to account for a larger share of the global alogliptin benzoate API market in 2018.
Product Definition:
Alogliptin benzoate is an oral diabetes medication that belongs to the class of medications called DPP-4 inhibitors. It works by increasing the amount of insulin released by the pancreas and decreasing the amount of sugar made by the liver. Alogliptin benzoate is used to treat type 2 diabetes in adults.
Min Purity Less Than 98%:
Alogliptin Benzoate is a new generation weight management medicine that works by helping the body to burn fat. It's an off-patent drug, which was developed in Japan and later acquired by Novo Nordisk in 2010. Alogliptin has been found to be more effective than existing anti-obesity medicines at reducing body mass index (BMI) and improving weight loss maintenance.
Min Purity 98%-99%:
Min Purity 98%-99% is a high purity form of Alogliptin Benzoate API. It has been characterized using HPLC with an ultraviolet detector and by mass spectrometry. The chemical structure of Min Purity 98%-99% is very similar to that of human insulin, except the molecular weight is much higher (58 kDa). This high molecular weight helps in increasing the stability and potency of the drug at room temperature.
Application Insights:
The research application segment dominated the global alogliptin benzoylhippurate API market in terms of revenue share in 2017. This is attributed to extensive R&D initiatives by various companies for the development of novel therapeutic applications for alogliptin. For instance, Pfizer has a broad pipeline of innovative medicines based on Aloxi that are being developed for a number of indications including diabetes and cardiovascular diseases.
Pharmaceutical accounted for the second-largest share owing to extensive product usage in manufacturing pharmaceutical drugs including Januvia (Lixisenatide), Byetta (NPH insulin) and Basaglar (RAGA). The presence of a large pool of potential patients suffering from diabetes across the globe is expected to be one major driver responsible for driving growth over the forecast period.
Regional Analysis:
North America dominated the global alogliptin benzoyl API market in 2017. This is due to the presence of a large number of key pharmaceutical companies involved in R&D activities for new drug development. Moreover, increasing incidence of diabetes and obesity has also led North America to dominate the global market. Asia Pacific region is expected to grow at a lucrative rate over the forecast period owing to rising prevalence of diabetes and obesity as well as government initiatives for improving healthcare infrastructure & availability.
Asia Pacific was followed by Europe with respect high prevalence rates associated with obesity, which has led this region towards second position after North America in terms of revenue generation from 2012-2017.
Growth Factors:
- Increasing prevalence of diabetes: The global prevalence of diabetes is increasing rapidly. This is mainly due to the changing lifestyle and dietary habits of people across the world. As a result, there is an increase in the demand for drugs to treat diabetes. Alogliptin benzoate API is one such drug that helps in controlling blood sugar levels in patients with type 2 diabetes mellitus.
- Growing awareness about type 2 diabetes: There is growing awareness among people about type 2 diabetes and its associated risks. This has led to an increase in the number of people who are seeking treatment for this condition. Alogliptin benzoate API helps control blood sugar levels and thus reduces the risk of complications associated with type 2 diabetes mellitus .
Scope Of The Report
Report Attributes
Report Details
Report Title
Alogliptin Benzoate API Market Research Report
By Type
Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%
By Application
Research, Pharmaceutical
By Companies
Metrochem API, Hecpharm, Angle Bio Pharma, Jigs chemical, Yihe-Chem, Dasheng Pharmaceutical Tech, Tecoland, CAD Pharma, Hefei Home Sunshine Pharmaceutical Technology, Hangzhou Dragonpharm, Sinoway Industrial, Wisdom Pharmaceutical, MuseChem
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
200
Number of Tables & Figures
140
Customization Available
Yes, the report can be customized as per your need.
Global Alogliptin Benzoate API Market Report Segments:
The global Alogliptin Benzoate API market is segmented on the basis of:
Types
Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Research, Pharmaceutical
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Metrochem API
- Hecpharm
- Angle Bio Pharma
- Jigs chemical
- Yihe-Chem
- Dasheng Pharmaceutical Tech
- Tecoland
- CAD Pharma
- Hefei Home Sunshine Pharmaceutical Technology
- Hangzhou Dragonpharm
- Sinoway Industrial
- Wisdom Pharmaceutical
- MuseChem
Highlights of The Alogliptin Benzoate API Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Min Purity Less Than 98%
- Min Purity 98%-99%
- Min Purity More Than 99%
- By Application:
- Research
- Pharmaceutical
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Alogliptin Benzoate API Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Alogliptin Benzoate API is a prescription medication used to lower blood sugar in people with type 2 diabetes. It works by helping the body to better use insulin.
Some of the major companies in the alogliptin benzoate api market are Metrochem API, Hecpharm, Angle Bio Pharma, Jigs chemical, Yihe-Chem, Dasheng Pharmaceutical Tech, Tecoland, CAD Pharma, Hefei Home Sunshine Pharmaceutical Technology, Hangzhou Dragonpharm, Sinoway Industrial, Wisdom Pharmaceutical, MuseChem.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Alogliptin Benzoate API Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Alogliptin Benzoate API Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Alogliptin Benzoate API Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Alogliptin Benzoate API Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Alogliptin Benzoate API Market Size & Forecast, 2020-2028
4.5.1 Alogliptin Benzoate API Market Size and Y-o-Y Growth
4.5.2 Alogliptin Benzoate API Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Min Purity Less Than 98%
5.2.2 Min Purity 98%-99%
5.2.3 Min Purity More Than 99%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Research
6.2.2 Pharmaceutical
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Alogliptin Benzoate API Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Alogliptin Benzoate API Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Min Purity Less Than 98%
9.6.2 Min Purity 98%-99%
9.6.3 Min Purity More Than 99%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Research
9.10.2 Pharmaceutical
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Min Purity Less Than 98%
10.6.2 Min Purity 98%-99%
10.6.3 Min Purity More Than 99%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Research
10.10.2 Pharmaceutical
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Min Purity Less Than 98%
11.6.2 Min Purity 98%-99%
11.6.3 Min Purity More Than 99%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Research
11.10.2 Pharmaceutical
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Min Purity Less Than 98%
12.6.2 Min Purity 98%-99%
12.6.3 Min Purity More Than 99%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Research
12.10.2 Pharmaceutical
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Min Purity Less Than 98%
13.6.2 Min Purity 98%-99%
13.6.3 Min Purity More Than 99%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Research
13.10.2 Pharmaceutical
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Alogliptin Benzoate API Market: Competitive Dashboard
14.2 Global Alogliptin Benzoate API Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Metrochem API
14.3.2 Hecpharm
14.3.3 Angle Bio Pharma
14.3.4 Jigs chemical
14.3.5 Yihe-Chem
14.3.6 Dasheng Pharmaceutical Tech
14.3.7 Tecoland
14.3.8 CAD Pharma
14.3.9 Hefei Home Sunshine Pharmaceutical Technology
14.3.10 Hangzhou Dragonpharm
14.3.11 Sinoway Industrial
14.3.12 Wisdom Pharmaceutical
14.3.13 MuseChem
